<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for New Invention Health Centre</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from April 2021 to August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where New Invention Health Centre is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=0204000U0&amp;denomIds=2.4&amp;selectedTab=summary">Atenolol with calcium channel blocker</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>27</td>
      <td>Beta-adrenoceptor blocking drugs</td>
      <td>1527</td>
      <td>0.02</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>18.85</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=0204000U0BCAAAA&amp;denomIds=2.4&amp;selectedTab=summary" target="_blank">Tenif 50mg/20mg modified-release capsules : 22</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=0204000U0AAAAAA&amp;denomIds=2.4&amp;selectedTab=summary" target="_blank">Atenolol 50mg / Nifedipine 20mg modified-release capsules : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=0601012AB&amp;denomIds=6.1.1&amp;selectedTab=summary">Insulin glargine/lixisenatide</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>6</td>
      <td>Intermediate and long-acting insulins</td>
      <td>288</td>
      <td>0.02</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>14.35</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=0601012ABBBABAB&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Suliqua 100units/ml / 50microg/ml inj 3ml pf SoloStar pens : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=0601012ABBBAAAA&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Suliqua 100units/ml / 33microg/ml inj 3ml pf SoloStar pens : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=0212000AL&amp;denomIds=2.12&amp;selectedTab=summary">Bempedoic acid/Ezetimibe</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2</td>
      <td>Lipid-regulating drugs</td>
      <td>3004</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>11.92</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=0212000ALBBAAAA&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Nustendi 180mg/10mg tablets : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=1106000T0&amp;denomIds=11.6&amp;selectedTab=summary">Levobunolol hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>10</td>
      <td>Treatment of glaucoma</td>
      <td>339</td>
      <td>0.03</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>8.11</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=1106000T0AAABAB&amp;denomIds=11.6&amp;selectedTab=summary" target="_blank">Levobunolol 0.5% eye drops 0.4ml unit dose preservative free : 10</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=0411000F0&amp;denomIds=4.11&amp;selectedTab=summary">Galantamine</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>31</td>
      <td>Drugs for dementia</td>
      <td>61</td>
      <td>0.51</td>
      <td>0.03</td>
      <td>0.06</td>
      <td>7.93</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=0411000F0AAAFAF&amp;denomIds=4.11&amp;selectedTab=summary" target="_blank">Galantamine 16mg modified-release capsules : 21</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=0411000F0BFABAF&amp;denomIds=4.11&amp;selectedTab=summary" target="_blank">Gatalin XL 16mg capsules : 10</a></div></td></tr></tbody></table>

        <h2>Prescribing where New Invention Health Centre is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=0502050C0&amp;denomIds=5.2.5&amp;selectedTab=summary">Terbinafine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>11</td>
      <td>Other antifungals</td>
      <td>14</td>
      <td>0.79</td>
      <td>0.99</td>
      <td>0.03</td>
      <td>-6.04</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=0502050C0AAAAAA&amp;denomIds=5.2.5&amp;selectedTab=summary" target="_blank">Terbinafine 250mg tablets : 11</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=1001040C0&amp;denomIds=10.1.4&amp;selectedTab=summary">Allopurinol</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>191</td>
      <td>Gout and cytotoxic induced hyperiuicaemia</td>
      <td>243</td>
      <td>0.79</td>
      <td>0.89</td>
      <td>0.05</td>
      <td>-2.03</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=1001040C0AAAAAA&amp;denomIds=10.1.4&amp;selectedTab=summary" target="_blank">Allopurinol 100mg tablets : 146</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=1001040C0AAABAB&amp;denomIds=10.1.4&amp;selectedTab=summary" target="_blank">Allopurinol 300mg tablets : 45</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=0905041R0&amp;denomIds=9.5.4&amp;selectedTab=summary">Zinc sulfate monohydrate</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Zinc</td>
      <td>2</td>
      <td>0.00</td>
      <td>0.73</td>
      <td>0.40</td>
      <td>-1.84</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=0105010B0&amp;denomIds=1.5.1&amp;selectedTab=summary">Mesalazine (Systemic)</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>36</td>
      <td>Aminosalicylates</td>
      <td>96</td>
      <td>0.38</td>
      <td>0.64</td>
      <td>0.15</td>
      <td>-1.81</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=0105010B0BCADAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 1g suppositories : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=0105010B0BIABAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Octasa 400mg MR gastro-resistant tablets : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=0105010B0BCACAI&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 500mg modified-release tablets : 16</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=0105010B0BIAAAS&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Octasa 800mg MR gastro-resistant tablets : 10</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=0105010B0AAAXAX&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g gast res MR gran sachets sugar free : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=1108010B0&amp;denomIds=11.8.1&amp;selectedTab=summary">Carbomer 940/980</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>12</td>
      <td>Tear deficiency, eye lubricant/astringent</td>
      <td>138</td>
      <td>0.09</td>
      <td>0.34</td>
      <td>0.15</td>
      <td>-1.70</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=1108010B0BCAAAB&amp;denomIds=11.8.1&amp;selectedTab=summary" target="_blank">GelTears 0.2% gel : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=1108010B0AAABAB&amp;denomIds=11.8.1&amp;selectedTab=summary" target="_blank">Carbomer '980' 0.2% eye drops : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=M91016&amp;numIds=1108010B0BBABAC&amp;denomIds=11.8.1&amp;selectedTab=summary" target="_blank">Viscotears 2mg/g eye gel 0.6ml unit dose : 5</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>